REG - Induction Healthcare - Form 8 (OPD) Induction Healthcare Group PLC
25/04/2025 11:15
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250425:nRSY2546Ga&default-theme=true
RNS Number : 2546G Induction Healthcare Group PLC 25 April 2025
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: INDUCTION HEALTHCARE GROUP PLC
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form INDUCTION HEALTHCARE GROUP PLC
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? OFFEREE
(e) Date position held: 24 April 2025
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security:
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil Nil Nil Nil
(2) Cash-settled derivatives: Nil Nil Nil Nil
(3) Stock-settled derivatives (including options) and agreements to Nil Nil Nil Nil
purchase/sell:
Nil Nil Nil Nil
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: None
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
a) Induction Healthcare Group PLC ordinary shares held by the directors of
Induction Healthcare Group PLC
Name of Director Number Induction Healthcare Group PLC ordinary shares held Percentage of total issued share capital (%)*
Christopher Samler 266,667 0.28%
Jane Silber 8,696 0.01%
Ian Johnson 20,000 0.02%
b) Options and awards in Induction Healthcare Group PLC held by the directors
of Induction Healthcare Group PLC
Name of Induction Healthcare Group PLC Director Number and Class of Securities Under Option Name of Scheme or Plan Exercise Price Vesting Details
Paul Tambeau 350,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 17/01/2024
Date fully Vested: 17/01/2026
Paul Tambeau 700,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 23/06/2024
Date fully Vested: 23/06/2026
Paul Tambeau 500,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 15/07/2024
Expiry Date: 15/07/2034
Initial Vesting Date: 05/07/2025
Date fully Vested: 05/07/2027
John McIntosh 500,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 23/06/2024
Date fully Vested: 23/06/2026
John McIntosh 350,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 15/07/2024
Expiry Date: 15/07/2034
Initial Vesting Date: 05/07/2024
Date fully Vested: 05/07/2026
b) Options and awards in Induction Healthcare Group PLC held by the directors
of Induction Healthcare Group PLC
Name of Induction Healthcare Group PLC Director Number and Class of Securities Under Option Name of Scheme or Plan Exercise Price Vesting Details
Paul Tambeau 350,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 17/01/2024
Date fully Vested: 17/01/2026
Paul Tambeau 700,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 23/06/2024
Date fully Vested: 23/06/2026
Paul Tambeau 500,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 15/07/2024
Expiry Date: 15/07/2034
Initial Vesting Date: 05/07/2025
Date fully Vested: 05/07/2027
John McIntosh 500,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 18/09/2023
Expiry Date: 18/09/2033
Initial Vesting Date: 23/06/2024
Date fully Vested: 23/06/2026
John McIntosh 350,000 ordinary shares of £0.005 each The Induction Healthcare Non Tax Advantaged Share Option Plan £0.005 Grant Date: 15/07/2024
Expiry Date: 15/07/2034
Initial Vesting Date: 05/07/2024
Date fully Vested: 05/07/2026
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None.
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None.
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 25 April 2025
Contact name: Paul Tambeau
Telephone number: +44 7983 104443
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEESEDFSIEISEFLRecent news on Induction Healthcare
See all newsREG - Singer Capital Induction Healthcare - Form 8.5 (EPT/RI) - Induction Healthcare Group PL
AnnouncementREG - StonehageFleming Inv Induction Healthcare - Form 8.3 - Induction Healthcare Group Plc
AnnouncementREG - Singer Capital Induction Healthcare - Form 8.5 (EPT/RI)
AnnouncementREG - Induction Healthcare - Form 8.3 - Induction Healthcare Group PLC
AnnouncementREG - Induction Healthcare - Form 8.3 - Induction Healthcare Group PLC
Announcement